Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Hottenrott, T; Dersch, R; Berger, B; Endres, D; Huzly, D; Thiel, J; Rauer, S; Stich, O; Salzer, U; Venhoff, N.
The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis.
BMC NEUROL. 2018; 18(1): 14 Doi: 10.1186/s12883-018-1018-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Thiel Jens
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Some rheumatologic disorders may initially manifest with central nervous system (CNS) affection, mimicking the clinical, magnetic resonance imaging, and cerebrospinal fluid findings of multiple sclerosis (MS). The MRZ reaction (MRZR), composed of the three respective antibody indices (AIs) against measles, rubella, and varicella zoster virus, has been found positive frequently in MS patients. However, it is unclear whether the MRZR is helpful to distinguish rheumatologic disorders with CNS involvement (RDwCNS) from MS. METHODS: The MRZR was evaluated in patients with RDwCNS (n = 23), MS (n = 46; age and sex matched to patients with RDwCNS), and other inflammatory autoimmune neurological diseases affecting the CNS (OIND; n = 48). Both the stringency levels that have been used in previous MRZR studies, MRZR-1 (≥ 1 of 3 AIs positive) and MRZR-2 (≥ 2 of 3 AIs positive), were applied. RESULTS: There was no statistically significant difference in the prevalence of positive MRZR between patients with RDwCNS (MRZR-1: 13.0% and MRZR-2: 8.7%, respectively) and OIND (MRZR-1: 22.9% and MRZR-2: 8.3%, respectively). Compared to these two study cohorts, the MS group exhibited significantly higher prevalences of positive MRZR (MRZR-1: 82.6%, MRZR-2: 63.0%; p < 0.005 each). CONCLUSIONS: Considering the high specificity of MRZR-2 for MS found in this study, MRZR-2 can be a useful diagnostic tool for distinguishing MS from RDwCNS or OIND.
Find related publications in this database (using NLM MeSH Indexing)
Adult - administration & dosage
Aged - administration & dosage
Antibodies, Viral - cerebrospinal fluid
Arthritis, Rheumatoid - diagnosis
Diagnosis, Differential - administration & dosage
Female - administration & dosage
Herpesvirus 3, Human - immunology
Humans - administration & dosage
Male - administration & dosage
Measles virus - immunology
Middle Aged - administration & dosage
Multiple Sclerosis - diagnosis
Retrospective Studies - administration & dosage
Rubella virus - immunology
Young Adult - administration & dosage

Find related publications in this database (Keywords)
Neuropsychiatric systemic lupus erythematosus (NPSLE)
ANCA-associated vasculitides
Behcet's disease
Multiple sclerosis (MS)
Intrathecal polyspecific antiviral immune response
MRZ reaction (MRZR)
© Med Uni Graz Impressum